ARGULIN Trademark

Trademark Overview


On Tuesday, December 7, 2021, a trademark application was filed for ARGULIN with the United States Patent and Trademark Office. The USPTO has given the ARGULIN trademark a serial number of 97160775. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, September 13, 2024. This trademark is owned by Kyon Biotech AG. The ARGULIN trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals for cancer treatment, excluding for treatment of blood cancers; pharmaceutical preparations for treating diabetes; pharmaceutical preparations and substances for the treatment of obesity; medical and veterinary preparations, namely, anticancer drugs and compounds for treating cancer, excluding for treatment of blood cancers, anti-diabetic pharmaceuticals and preparations, anti-obesity pharmaceuticals and preparations

Providing consumer information services relating to the selection of medical products

Medical services; medical services in the field of oncology; medical diagnostic testing services; medical clinic services; conducting of medical examinations; medical consultation regarding use and effectiveness of medical products; medical information; medical advisory services; medical analysis services, namely, medical analysis services for cancer diagnosis and prognosis; medical services in the field of diabetes; medical care

Medical and pharmacological research services; research on the subject of pharmaceuticals; scientific investigations for medical purposes; scientific research for medical purposes; development of pharmaceutical preparations and medicines
argulin

General Information


Serial Number97160775
Word MarkARGULIN
Filing DateTuesday, December 7, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateFriday, September 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements


Goods and ServicesPharmaceuticals for cancer treatment, excluding for treatment of blood cancers; pharmaceutical preparations for treating diabetes; pharmaceutical preparations and substances for the treatment of obesity; medical and veterinary preparations, namely, anticancer drugs and compounds for treating cancer, excluding for treatment of blood cancers, anti-diabetic pharmaceuticals and preparations, anti-obesity pharmaceuticals and preparations
Goods and ServicesProviding consumer information services relating to the selection of medical products
Goods and ServicesMedical services; medical services in the field of oncology; medical diagnostic testing services; medical clinic services; conducting of medical examinations; medical consultation regarding use and effectiveness of medical products; medical information; medical advisory services; medical analysis services, namely, medical analysis services for cancer diagnosis and prognosis; medical services in the field of diabetes; medical care
Goods and ServicesMedical and pharmacological research services; research on the subject of pharmaceuticals; scientific investigations for medical purposes; scientific research for medical purposes; development of pharmaceutical preparations and medicines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, December 19, 2022
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 13, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 13, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKyon Biotech AG
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressZürich 8005
CH

Party NameKyon Biotech AG
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressZürich 8005
CH

Trademark Events


Event DateEvent Description
Tuesday, September 13, 2022SUSPENSION LETTER WRITTEN
Friday, December 10, 2021NEW APPLICATION ENTERED
Monday, December 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 13, 2022ASSIGNED TO EXAMINER
Tuesday, September 13, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, September 13, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 20, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, December 10, 2022ASSIGNED TO LIE
Monday, December 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 15, 2022DATA MODIFICATION COMPLETED
Monday, December 19, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, December 19, 2022EXAMINERS AMENDMENT E-MAILED
Monday, December 19, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 19, 2022EXAMINER'S AMENDMENT ENTERED
Monday, December 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 21, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, July 13, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, July 21, 2023OPPOSITION INSTITUTED NO. 999999
Thursday, July 27, 2023CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Saturday, August 12, 2023OPPOSITION DISMISSED NO. 999999
Tuesday, July 25, 2023ASSIGNED TO PETITION STAFF
Saturday, August 12, 2023OPPOSITION TERMINATED NO. 999999
Saturday, August 12, 2023TTAB RELEASE CASE TO TRADEMARKS
Tuesday, September 26, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 19, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 27, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, December 27, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, February 19, 2024SOU EXTENSION 1 FILED
Monday, February 19, 2024SOU EXTENSION 1 GRANTED
Friday, September 13, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 13, 2024SOU EXTENSION 2 FILED
Friday, September 13, 2024SOU EXTENSION 2 GRANTED